血管低频疾病联盟:罕见血管疾病的多机构协作研究方法
本文介绍血管低频疾病联盟(VLFDC)通过系统文献综述识别罕见血管疾病、建立疾病特异性数据库并在多机构标准化收集数据的方法。自2003年以来已完成9项研究、纳入4532例患者、涉及232家机构和271名研究者,每项研究样本量至少为既往研究的10倍。
要点
- VLFDC为罕见血管疾病提供多机构标准化数据收集与集中分析框架
- 已发表9项研究涵盖肾动脉瘤、孤立性股动脉瘤、自发性肠系膜夹层等疾病
- 每项研究样本量至少为既往同期的10倍,可验证或挑战传统管理原则
核心结论
- 当罕见血管疾病仅有小样本临床系列或治疗推荐存在冲突时,多机构联盟可提供大容量标准化数据以确认或改变既往管理原则。
研究设计与样本
- 通过系统文献综述识别罕见血管疾病,建立疾病特异性数据库并在单机构测试后推广至VLFDC参与机构。
- 自2003年以来VLFDC已开展并发表9项研究,纳入4532例患者,涉及232家机构和271名研究者。
主要发现
- 已发表研究涵盖肾动脉瘤、孤立性股动脉瘤、自发性肠系膜夹层、外膜囊性疾病、颈动脉体瘤和血管型埃勒斯-当洛斯综合征。
- 每项已发表研究报道的患者数至少为既往同期发表研究收集数的10倍。
- 每项研究既确认了基于小规模单机构经验的既往管理原则,也挑战了传统管理范式。
临床怎么用
- 对罕见血管疾病,可通过VLFDC模式开展多机构标准化数据收集与集中分析,以弥补标准化数据库覆盖不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Standardized databases such as the Vascular Quality Initiative and National Surgical Quality Improvement Project assess the quality of care related to common vascular surgery procedures, but are not designed for uncommon vascular diseases. We describe a method of assessing uncommon vascular diseases using a multi-institutional collaboration, the Vascular Low Frequency Disease Consortium (VLFDC). METHODS: Uncommon vascular diseases are identified through a systematic literature review. A disease-specific database is developed and tested at a single institution, then refined and circulated to participating VLFDC investigators. Detailed inclusion and exclusion criteria and data point definitions are provided, allowing for standardized data collection across institutions. Each participating institution identifies all patients over a specific time period and enters the data into a VLFDC-provided database. The data are then de-identified and transmitted to our centralized data center for analysis. RESULTS: Since 2003, the VLFDC has conducted and published nine studies and enrolled 4532 patients, involving 232 institutions and 271 investigators. The studies include renal artery aneurysms, isolated femoral artery aneurysms, spontaneous mesenteric dissection, adventitial cystic disease, carotid body tumors, and vascular Ehlers-Danlos syndrome. Each published study reported on a minimum of 10 times the number of patients collected in previously published studies over the same time period, allowing stronger conclusions to be drawn from the larger sample size. Each study both confirmed previous management principles, which were based on small single-institution experiences, and challenged conventional management paradigms. CONCLUSIONS: When only small clinical series exist to provide guidance in managing uncommon vascular diseases, and/or where conflicting recommendations are made on the treatment of uncommon vascular diseases, a multi-institutional consortium can provide high-volume standardized data that either confirm or changes prior management principles.
引用
- Lawrence PF, Baril DT, Woo K, et al. Investigating uncommon vascular diseases using the Vascular Low Frequency Disease Consortium. J Vasc Surg. 2020. PMID: 31964572. doi:10.1016/j.jvs.2019.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。